Tags: Hemophilia Ainhibitor formationprophylaxisadherenceSpecialty Pharmacists
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA | Novo Nordisk Adds to Manufacturing Capacity, Pumping Billions Into New Rare Disease Site - 11 days ago | |
| 2 | Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts | ||
| 3 | Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California | ||
| 4 | Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland | Arrowhead Pharmaceuticals Submits FDA Application for Plozasiran in Familial Chylomicronemia Syndrome - about 1 month ago | |
| 5 | Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | ELA026 Receives Orphan Drug Designation to Treat Hemophagocytic Lymphohistiocytosis - about 2 months ago High-Risk Pediatric Patients With Antiphospholipid Syndrome Present Risk of Severe Health Issues - about 1 year ago Children Remain High Risk for Antiphospholipid Syndrome - about 1 year ago | |
| 6 | Meagan Parrish Pharma Voice Senior editor @industrydive.
Pharma world follower. Wisconsin, USA | A sickle cell cure exists. But patients need more than just gene therapy. - about 2 months ago | |
| 7 | Hannah Thomasy, PhD The Scientist Freelance science writer. PhD. Seattle & Toronto | Why Do People Have Different Blood Types? - 3 months ago | |
| 8 | Jason Mast STAT News Writing about science, medicine. | ||
| 9 | Nicole Lou MedPage Today Medical reporter @medpagetoday. Bird advocate. undisclosed remote location | Alteplase Not Harmful in NOAC Users, Even in a More Bleeding-Prone Cohort - about 1 year ago Consequences of Oral Anticoagulant Choice Magnified in the Frail - about 1 year ago | |
| 10 | James Woodford New Scientist Ocean Correspondent. South Coast, New South Wales |